RYALTRIS FDA approval date

The FDA approved RYALTRIS on 13 Jan 2022.

FDA approval date
13 Jan 2022

Drug identity has not yet been verified against registry records

Also recorded as MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-01-13DayRYALTRISFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211746", "applicant_as_listed_by_fda": "GLENMARK SPECLT", "brand_names": ["RYALTRIS"], "active_ingredients": ["MOMETASONE FUROATE", "OLOPATADINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220113", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026